semaglutide cardiovascular trial 6 risk reduction with once-weekly in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV Wegovy confers reductions in cardiovascular

Lost in translation: How can education about dementia be effectively integrated into medical school contexts

For those living with Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), the daily reality often involves crushing post-exertional malaise (PEM), severe cognitive dysfunction, and autonomic nervous system flares that make normal life impossible

You're not alone, and there's a solution that flies under the radar for most guys on testosterone replacement ther

It's essential for converting food into glucose, which the body uses for energy, contributing to the synthesis of neurotransmitters that support brain health

In a 68-week trial involving non-diabetic adults with overweight or obesity, the efficacy and safety of weekly subcutaneous semaglutide (2.4mg) and once-daily subcutaneous liraglutide (3.0mg) were compared [10]

Reactive oxygen species-dependent wound responses in animals and plants